HUP0400775A2 - Specific human antibodies for selective cancer therapy - Google Patents

Specific human antibodies for selective cancer therapy

Info

Publication number: HUP0400775A2
Authority: HU; Hungary
Prior art keywords: human antibodies; cancer therapy; specific human; selective cancer; selective
Prior art date: 2000-12-29

Application number

HU0400775A

Other languages

Hungarian (hu)

Inventor

Yocheved Hagai

Janette Lazarovits

Rachel Guy

Orly Lipschitz

Ester Szanthon

Avigdor Levanon

Daniel Plaksin

Tuvia Peretz

Original Assignee

Bio Technology General Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-29

Filing date

2001-12-31

Publication date

2007-05-02

2001-12-31 Application filed by Bio Technology General Corp filed Critical Bio Technology General Corp

2007-05-02 Publication of HUP0400775A2 publication Critical patent/HUP0400775A2/en

Links

238000011275 oncology therapy Methods 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/472—Complement proteins, e.g. anaphylatoxin, C3a, C5a
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

HU0400775A 2000-12-29 2001-12-31 Specific human antibodies for selective cancer therapy HUP0400775A2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US75118100A	2000-12-29	2000-12-29
PCT/US2001/049440 WO2002059264A2 (en)	2000-12-29	2001-12-31	Specific human antibodies for selective cancer therapy

Publications (1)

Publication Number	Publication Date
HUP0400775A2 true HUP0400775A2 (en)	2007-05-02

Family

ID=25020844

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU0400775A HUP0400775A2 (en)	2000-12-29	2001-12-31	Specific human antibodies for selective cancer therapy

Country Status (15)

Country	Link
EP (1)	EP1353937A4 (en)
JP (1)	JP2004524023A (en)
KR (1)	KR20030091952A (en)
CN (1)	CN100374456C (en)
AU (1)	AU2002246737B2 (en)
BR (1)	BR0116763A (en)
CA (1)	CA2433227A1 (en)
CZ (1)	CZ20031983A3 (en)
HU (1)	HUP0400775A2 (en)
IL (1)	IL156690A0 (en)
MX (1)	MXPA03005944A (en)
NZ (1)	NZ527173A (en)
PL (1)	PL365758A1 (en)
RU (1)	RU2316564C2 (en)
WO (1)	WO2002059264A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1551452A4 (en) *	2002-07-01	2006-08-30	Savient Pharmaceuticals Inc	Compositions and methods for therapeutic treatment
JP2007527393A (en) *	2003-06-30	2007-09-27	バイオ−テクノロジー・ジェネラル（イスラエル）リミテッド	Specific human antibodies
AU2006238930B2 (en)	2005-04-26	2010-12-23	Pfizer Inc.	P-cadherin antibodies
WO2010078916A1 (en) *	2008-12-19	2010-07-15	Philogen S.P.A.	Immunocytokines for tumour therapy with chemotherapeutic agents
DK2933262T3 (en) *	2010-07-09	2018-06-25	Affibody Ab	polypeptides
CN101948534B (en) *	2010-08-19	2014-05-28	中国科学院生物物理研究所	Method for screening antibodies
GB201310544D0 (en) *	2013-06-13	2013-07-31	Ucb Pharma Sa	Obtaining an improved therapeutic ligand
RS59063B1 (en) *	2014-10-23	2019-08-30	Singh Biotechnology Llc	Single domain antibodies directed against intracellular antigens
US20160176983A1 (en) *	2014-12-17	2016-06-23	Intrexon Corporation	Intercalated single-chain variable fragments
GB201506868D0 (en) *	2015-04-22	2015-06-03	Ucb Biopharma Sprl	Method for protein purification
WO2017055635A1 (en) *	2015-10-01	2017-04-06	Ospedale San Raffaele S.R.L.	Tcr and uses thereof
EP3377103B1 (en) *	2015-11-19	2021-03-17	Revitope Limited	Functional antibody fragment complementation for a two-components system for redirected killing of unwanted cells
KR20230035706A (en) *	2016-09-14	2023-03-14	테네오원, 인코포레이티드	Cd3 binding antibodies
IL302791A (en) *	2020-11-13	2023-07-01	Prometheus Biosciences Inc	Methods, systems, and kits for treatment of inflammatory diseases targeting tl1a

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1997002479A2 (en) *	1995-06-30	1997-01-23	Yale University	Human monoclonal anti-tumor antibodies
IL130908A0 (en) *	1997-01-22	2001-01-28	Univ Texas	Tissue-factor (tf) compositions for coagulation and tumor treatment

2001
- 2001-12-31 WO PCT/US2001/049440 patent/WO2002059264A2/en active IP Right Grant
- 2001-12-31 CN CNB018228852A patent/CN100374456C/en not_active Expired - Fee Related
- 2001-12-31 MX MXPA03005944A patent/MXPA03005944A/en not_active Application Discontinuation
- 2001-12-31 CA CA002433227A patent/CA2433227A1/en not_active Abandoned
- 2001-12-31 PL PL01365758A patent/PL365758A1/en unknown
- 2001-12-31 HU HU0400775A patent/HUP0400775A2/en unknown
- 2001-12-31 JP JP2002559551A patent/JP2004524023A/en active Pending
- 2001-12-31 CZ CZ20031983A patent/CZ20031983A3/en unknown
- 2001-12-31 BR BR0116763-4A patent/BR0116763A/en not_active IP Right Cessation
- 2001-12-31 AU AU2002246737A patent/AU2002246737B2/en not_active Ceased
- 2001-12-31 IL IL15669001A patent/IL156690A0/en unknown
- 2001-12-31 KR KR10-2003-7008885A patent/KR20030091952A/en not_active Application Discontinuation
- 2001-12-31 EP EP01994329A patent/EP1353937A4/en not_active Withdrawn
- 2001-12-31 NZ NZ527173A patent/NZ527173A/en unknown
- 2001-12-31 RU RU2003123100/13A patent/RU2316564C2/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
PL365758A1 (en)	2005-01-10
MXPA03005944A (en)	2005-04-29
CZ20031983A3 (en)	2005-07-13
EP1353937A4 (en)	2005-04-13
WO2002059264A2 (en)	2002-08-01
KR20030091952A (en)	2003-12-03
AU2002246737B2 (en)	2007-03-01
CN100374456C (en)	2008-03-12
RU2316564C2 (en)	2008-02-10
IL156690A0 (en)	2004-01-04
NZ527173A (en)	2006-03-31
JP2004524023A (en)	2004-08-12
EP1353937A2 (en)	2003-10-22
CN1551886A (en)	2004-12-01
BR0116763A (en)	2004-03-09
RU2003123100A (en)	2005-03-10
CA2433227A1 (en)	2002-08-01
WO2002059264A3 (en)	2003-03-06

Legal Events

Date	Code	Title	Description
2008-08-28	FD9A	Lapse of provisional protection due to non-payment of fees

Publication	Publication Date	Title
EP1311262A4 (en)	2005-06-01	Cancer treatment by combination therapy
GB2386120B (en)	2005-03-09	Differentiated cells suitable for human therapy
EP1572131A4 (en)	2009-07-29	Antibody therapy
EP1296699A4 (en)	2005-02-16	Therapeutic agents - iii
GB0028429D0 (en)	2001-01-10	Therapy
IL214262A0 (en)	2011-08-31	Therapeutic human anti-il-1r1 monoclonal antibody
AU2001251348A1 (en)	2001-10-23	Apparatus for sensing human prostate tumor
HUP0400775A2 (en)	2007-05-02	Specific human antibodies for selective cancer therapy
HUP0300005A3 (en)	2005-09-28	Modified cytokines for use in cancer therapy
GB2367993B (en)	2005-04-20	Radiotherapy apparatus
EP1178829A4 (en)	2005-06-08	Human monoclonal antibody
AU2002351374A8 (en)	2003-06-23	Antibodies to treat cancer
GB0001710D0 (en)	2000-03-15	Therapeutic treatment
GB0005257D0 (en)	2000-04-26	Breast cancer hormonal therapy
EP1401494A4 (en)	2005-02-23	Tumor therapy
AU144325S (en)	2001-07-05	Therapy device
AU2096002A (en)	2002-06-18	Therapeutic treatment
GB0026015D0 (en)	2000-12-13	Cancer treatment
GB2374018B (en)	2003-11-19	Ultrasound therapy
GB0022216D0 (en)	2000-10-25	Human FAP-a-specific antibodies for use in cancer therapy
EP1463511A4 (en)	2005-09-28	Combination cancer therapy
SI1157041T1 (en)	2005-12-31	Antibodies for cancer therapy and diagnosis
GB0024673D0 (en)	2000-11-22	Therapeutic antibodies
GB9914057D0 (en)	1999-08-18	Antibody therapy
GB9927698D0 (en)	2000-01-19	Therapeutic antibody